Skip to main content
Premium Trial:

Request an Annual Quote

Who Doesn't Want More Laws?

PredictER blogs that there's more to GINA than what's being discussed. The post points to the overlooked Title II, Section 208, Subsection (b). That part provides for a Genetic Nondiscrimination Study Commission to be enacted six years after GINA was passed. The commission will study the state of genetics, genetic discrimination, public perception, among others, and recommend any possible further legislation to Congress. "Here, it would seem as though Congress has exercised a reasonable amount of foresight," says PredictER.

The Scan

Could Cost Billions

NBC News reports that the new Alzheimer's disease drug from Biogen could cost Medicare in the US billions of dollars.

Not Quite Sent

The Biden Administration likely won't meet its goal of sending 80 million SARS-CoV-2 vaccine doses abroad by the end of the month, according to the Washington Post.

DTC Regulation Proposals

A new report calls on UK policymakers to review direct-to-consumer genetic testing regulations, the Independent reports.

PNAS Papers on Mosquito MicroRNAs, Acute Kidney Injury, Trichothiodystrophy

In PNAS this week: microRNAs involved in Aedes aegypti reproduction, proximal tubule cell response to kidney injury, and more.